Vounatsos Michel
Chief Executive Officer and Director
pharmaceutics
Pharmaceutical Sciences
United States of America
Biography
Michel Vounatsos is Chief Executive Officer at Biogen and has served in this position and as a member of the Board of Directors since January 2017. Michel joined Biogen in 2016 as Executive Vice President, Chief Commercial Officer after a 20 career at Merck. While at Merck, he held leadership positions of increasing responsibility in Europe, China, and the U.S., driving significant and consistent growth across multiple geographies. Most recently, he served as President, Primary Care Business Line and Merck Customer Centricity leading Merck’s global primary care business unit, a role which encompassed Merck’s cardiology-metabolic, general medicine, women’s health and biosimilars groups, and developed and instituted a strategic framework for enhancing the company’s relationships with key constituents, including providers, payers and retailers and governmental bodies throughout the world. Earlier in his career, Michel held management positions at Ciba-Geigy.
Research Interest
Pharma and Pharmaceutical Science
